David Ludwig’s practice focuses on patent litigation and counseling in a wide variety of industries, ranging from electronics, software, and telecommunications to pharmaceuticals, medical devices, and scientific instruments. He has also litigated cases pertaining to copyrights, trademarks, and administrative law. David is adept at all stages of litigation, having served as counsel, including as lead counsel, in several district court trials and several appeals. His representative matters include high-stakes patent infringement suits regarding pharmaceuticals with annual sales in the hundreds of millions of dollars. David is also licensed to practice before the U.S. Patent and Trademark Office and has represented clients in multiple inter partes review and interference proceedings.
Clients rely on David for his broad-based scientific expertise, deep knowledge of patent law, and sharp analytical skills. A student of physics and having spent his career working closely with leading experts in various technical fields, David can quickly understand and analyze a wide range of new technologies and associated patent rights. He is able to efficiently assess case merits and develop potent litigation strategy under tight time constraints, allowing clients to make timely strategic decisions in urgent situations.
While David is first and foremost a litigator, he is also trained in business and holds an M.B.A. David’s education and interest in business decision-making permits him to see beyond the mere legal issues facing clients to the business realities that must often take precedence. As a result, clients have recognized David as a key asset in counseling on patent-related issues and strategy, leading David to be named a “New Leader in the Law” by the Connecticut Law Tribune.
- Intellectual Property
- Patent Litigation
- University of Virginia School of Law, J.D.
- Union Graduate College, M.B.A.
- Magna cum laude
- Beta Gamma Sigma Business Honor Society
- Union College, B.S.
- Physics and Philosophy Double Major
- Magna cum laude
- Harold A. Larrabee Prize for Excellence in Philosophy
- U.S. Patent and Trademark Office
- U.S. Court of Appeals for the Federal Circuit
- U.S. Court of Appeals for the Second Circuit
- U.S. District Court for the District of Connecticut
- Not admitted to the Georgia Bar
- Susceptibility of Digital Products to Section 271(g) in the Age of Cloud Computing, Artificial Intelligence, Blockchains, and 3D Printing, 4(2) J. ROBOTICS, ARTIFICIAL INTELLIGENCE & LAW 85 (January 11, 2021)
- Quest Integrity v. Cokebusters Puts Cloud-Based Medical Diagnostic Patents at Risk of On-Sale Bar, MED. DEVICE & DIAGNOSTIC IND. (February 10, 2020)
- Drug-Pricing Bill Threatens Robust Generics Industry, LAW360 (December 13, 2019)
- Fed. Circ. Ruling May Affect Eligibility of Life Sciences Patents, LAW360 (November 21, 2019)
- Fed. Circ. Muddies Waters on Method-of-Treatment Patents, LAW360 (September 4, 2019)
- Method-of-Treatment Patent Eligibility: Step 1 and Done?, LAW360 (February 5, 2019)
- Joint Infringement Post-Akamai: Understanding the Impact on Prosecution and Litigation Strategies, THE INTELLECTUAL PROPERTY STRATEGIST (January 2017 and February 2017) (published in two parts)